Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 1 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung CancerNot yet recruitingNCT07892300Early Phase 1
- A Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]RecruitingNCT07890714Phase 1/2
- Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLCNot yet recruitingNCT07890636Phase 2
- Immune Checkpoint Blockade and Chemotherapy With or Without Fecal Microbiota Transplant in Advanced Non-Small Cell Lung CancerNot yet recruitingNCT07890493Phase 2
- A Phase 1 Study of IM-1340 in Participants With Advanced CancerNot yet recruitingNCT07890246Phase 1
- Pulsed Field Ablation for the Treatment of Malignant Lung TumorsNot yet recruitingNCT07889297Not applicable
- Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07889232Phase 1/2
- OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingNCT07888075Phase 2/3
- A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid TumorsRecruitingNCT07887971Phase 1
- Effects of Supervised Aerobic Exercise on Biomarkers in Patients With nSCLC Receiving ImmunotherapyNot yet recruitingNCT07886359Not applicable
- Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung CancerRecruitingNCT07886229Phase 1
- MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLCNot yet recruitingNCT07885709Phase 2
- Becotatug Vedotin + Pucotenlimab+Platinum Induction and Sequential CCRT for Unresectable LA NSCLCNot yet recruitingNCT07882940Phase 2
- Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast CancerNot yet recruitingNCT07880106
- Acupuncture and Laser Acupuncture for Advanced Non-Small Cell Lung CancerNot yet recruitingNCT07879768Not applicable
- PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%Not yet recruitingNCT07877584Phase 3
- Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver MetastasesNot yet recruitingNCT07875465Phase 2
- SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung CancerNot yet recruitingNCT07874984Phase 2
- Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLCRecruitingNCT07874490Phase 2
- Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course Immunotherapy or Consolidation Immunotherapy for Locally Advanced NSCLCNot yet recruitingNCT07874464Phase 2
- SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-METRecruitingNCT07873450Phase 1/2
- MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLCNot yet recruitingNCT07873086Not applicable
- A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)Not yet recruitingNCT07871214Phase 2
- Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer PatientsNot yet recruitingNCT07869329Not applicable
- Dermatological Effects and Quality of Life in Oncology PatientsNot yet recruitingNCT07869186Not applicable
- A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07865910Phase 2/3
- Study Using a Drug-device Combination Product to Determine Safety, Tolerability and Antitumor Activity for Patients With Advanced, Non-small Cell Lung CancerNot yet recruitingNCT07864584Phase 1/2
- An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.Not yet recruitingNCT07863167Phase 2
- Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on TumorsNot yet recruitingNCT07863024Phase 1/2
- SI-B036-ST-101 in Advanced/Metastatic Solid TumorsNot yet recruitingNCT07857616Phase 1
- Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerRecruitingNCT07855965Phase 2
- Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung CancerNot yet recruitingNCT07854769
- An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung CancerNot yet recruitingNCT07849712Not applicable
- Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide ProbesRecruitingNCT07848243Phase 2
- This is a Multicenter, Open-label, Phase I/II Study to Explore the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of GFH276 in Patients With Advanced NSCLC Harboring a RAS Mutation.Not yet recruitingNCT07846358Phase 1/2
- Quad Shot Radiotherapy Combined With Tislelizumab and Platinum-Based Chemotherapy Before Surgery for Stage II-III Non-Small Cell Lung CancerNot yet recruitingNCT07845916Phase 2
- Local Consolidative Therapy Versus Maintenance Immunotherapy After First-Line Chemoimmunotherapy in Metastatic NSCLCNot yet recruitingNCT07842471Phase 2
- Cardiorespiratory Fitness After Lobectomy Versus Sublobar ResectionRecruitingNCT07841249
- Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain MetastasesNot yet recruitingNCT07841106Phase 2
- Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLCRecruitingNCT07837739
- Trastuzumab Rezetecan and Adebrelimab, Alone or in Combination, After Chemoradiotherapy for HER2-Altered Unresectable Stage III Lung CancerNot yet recruitingNCT07836543Phase 2
- CAIX-targeted PET/CT in Solid TumorsRecruitingNCT07833085Not applicable
- Perioperative Targeted Therapy in Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer With Rare Driver MutationsNot yet recruitingNCT07829744Phase 2
- Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung CancerNot yet recruitingNCT07828938Not applicable
- A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07827261Phase 2
- A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsRecruitingNCT07824882Phase 2
- SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLCRecruitingNCT07823855Not applicable
- TailorDose Lung: Decentralized TDM of Taxanes and ALK Inhibitors Using Capillary Self-SamplingNot yet recruitingNCT07823725Not applicable
- Consolidative Stereotactic Radiotherapy for Oligo-Residual Advanced EGFR-Mutant NSCLC After First-Line Third-Generation EGFR-TKI Plus ChemotherapyNot yet recruitingNCT07822984Phase 2
- A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in IndiaNot yet recruitingNCT07822880Phase 4
- A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNot yet recruitingNCT07822542Phase 3
- A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung CancerNot yet recruitingNCT07821684Phase 3
- Toripalimab Plus Sacituzumab Tirumotecan as Neoadjuvant Therapy for Resectable NSCLCNot yet recruitingNCT07819578Phase 2
- SRT Combined With Envafolimab and Endostar in the First-line Treatment of Advanced NSCLCNot yet recruitingNCT07818304Phase 2
- Comparison of Biportal Versus Multiportal Robotic Approaches for Pulmonary Resection in NSCLCRecruitingNCT07818135Not applicable
- NUT Project: Nutritional Support in Thoracic OncologyRecruitingNCT07817329
- A Phase III Study to Evaluate the Efficacy and Safety of JYP0322 in Previously Untreated ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07816380Phase 3
- Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic CancersNot yet recruitingNCT07815873Not applicable
- A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid TumorsRecruitingNCT07814248Phase 1
- Wireless Wearable Home Prehabilitation for Older Adults With NSCLCRecruitingNCT07809763Not applicable
- A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastatic Non-small Cell Cancer With a RET Gene TranslocationRecruitingNCT07809256Phase 3
- RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung CancerNot yet recruitingNCT07808138Phase 2
- A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsRecruitingNCT07807956Phase 1
- Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLCNot yet recruitingNCT07807722Phase 2
- Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticRecruitingNCT07807345Phase 1
- Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung CancerNot yet recruitingNCT07806773Phase 2
- Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung CancerRecruitingNCT07806604
- Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLCNot yet recruitingNCT07802834Phase 2
- A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid TumorsRecruitingNCT07801508Phase 1
- Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLCRecruitingNCT07801430Not applicable
- Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy StudyNot yet recruitingNCT07799194Not applicable
- Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer ResectionNot yet recruitingNCT07797075Not applicable
- Low-Frequency rTMS for In-Hospital Sleep Disturbance in Advanced NSCLCNot yet recruitingNCT07796438Phase 2
- YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07793500Early Phase 1
- Surgical Outcome Of da Vinci Single-port Surgical System In Lung CancerRecruitingNCT07790406
- BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor MalignanciesRecruitingNCT07789912Not applicable
- Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain MetsNot yet recruitingNCT07789444Phase 2
- ERICA-02 Study : Impact of Physical Exercise on the Tumor Immune Microenvironment in Patients Treated With Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung CancerNot yet recruitingNCT07786909Not applicable
- Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical RelevanceRecruitingNCT07783971
- An Expanded Access Program to Provide Divarasib to Participants With Previously Treated KRAS G12c-Positive Advanced or Metastatic Non-Small Cell Lung CancerAvailableNCT07783009
- Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNot yet recruitingNCT07781852Early Phase 1
- Septum-guided Segmentectomy for 2-3 cm Clinical Stage IA3 Peripheral Non-Small Cell Lung CancerNot yet recruitingNCT07780591Not applicable
- The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07780578Phase 2
- Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLCRecruitingNCT07777822Phase 3
- OPTIMISE Lung SABRRecruitingNCT07777614Phase 2
- Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II TrialNot yet recruitingNCT07775040Phase 2
- A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral NeuropathyRecruitingNCT07774520Phase 2
- Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)RecruitingNCT07770100Phase 2
- Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07761910Phase 2
- A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCNot yet recruitingNCT07760519
- A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult ParticipantsRecruitingNCT07756645Phase 3
- Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCRecruitingNCT07754812Phase 4
- Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.RecruitingNCT07754409
- Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCNot yet recruitingNCT07754123Phase 3
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLCNot yet recruitingNCT07752589
- Development and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsRecruitingNCT07751783Not applicable
- ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to Third-Generation TKIs in the Consolidation PhaseRecruitingNCT07751536Not applicable
- Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With PembrolizumabRecruitingNCT07751042Phase 1/2
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2